Annaliesa S Anderson Selected Research

COVID-19

3/2024	Serum Troponin I Assessments in 5- to 30-Year-Olds After BNT162b2 Vaccination.
8/2023	Safety, Tolerability, and Pharmacokinetics of Single and Multiple Ascending Intravenous Infusions of PF-07304814 (Lufotrelvir) in Participants Hospitalized With COVID-19.
1/2023	Therapeutics for COVID-19.
1/2022	Genetic Surveillance of SARS-CoV-2 Mpro Reveals High Sequence and Structural Conservation Prior to the Introduction of Protease Inhibitor Paxlovid.
1/2022	Nirmatrelvir-Ritonavir and Viral Load Rebound in Covid-19.
1/2022	Innovative Randomized Phase I Study and Dosing Regimen Selection to Accelerate and Inform Pivotal COVID-19 Trial of Nirmatrelvir.
12/2021	An oral SARS-CoV-2 Mpro inhibitor clinical candidate for the treatment of COVID-19.
10/2021	Preclinical characterization of an intravenous coronavirus 3CL protease inhibitor for the potential treatment of COVID19.
10/2021	A comparative analysis of SARS-CoV-2 antivirals characterizes 3CLpro inhibitor PF-00835231 as a potential new treatment for COVID-19.
2/2021	A comparative analysis of SARS-CoV-2 antivirals in human airway models characterizes 3CLpro inhibitor PF-00835231 as a potential new treatment for COVID-19.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Annaliesa S Anderson Research Topics

Disease

26	Infections 01/2023 - 09/2003
13	Meningococcal Infections 01/2023 - 08/2010
12	COVID-19 03/2024 - 11/2020
3	Sepsis (Septicemia) 05/2024 - 06/2013
3	Cross Infection (Nosocomial Infection) 01/2020 - 04/2006
3	Bacteremia 09/2013 - 05/2009
2	Pharyngitis (Sore Throat) 12/2023 - 12/2022
2	Pain (Aches) 01/2021 - 01/2020
2	Wound Infection (Wound Infections) 09/2013 - 05/2009
2	Wounds and Injuries (Trauma) 06/2013 - 09/2003
2	Staphylococcal Infections 01/2013 - 09/2003
1	Neonatal Sepsis 05/2024
1	Myocarditis (Carditis) 03/2024
1	Pericarditis 03/2024
1	Human Influenza (Influenza) 09/2023
1	Otitis Media 12/2022
1	Virus Diseases (Viral Diseases) 12/2022
1	Diarrhea 01/2020
1	Community-Acquired Infections 01/2020
1	Streptococcal Infections (Streptococcal Infection) 01/2019
1	Meningococcal Meningitis 11/2016
1	Acquired Immunodeficiency Syndrome (AIDS) 01/2014
1	Chronic Kidney Failure (Chronic Renal Failure) 06/2013
1	Soft Tissue Infections 06/2013
1	Respiratory Tract Infections (Respiratory Tract Infection) 01/2013
1	Tissue Adhesions 10/2012
1	Foreign Bodies (Foreign Body) 09/2003
1	Persistent Infection 09/2003
1	Abscess 09/2003

Drug/Important Bio-Agent (IBA)

34	VaccinesIBA 05/2024 - 04/2006
10	AntigensIBA 12/2023 - 05/2009
9	Antiviral Agents (Antivirals)IBA 08/2023 - 02/2021
5	Carrier Proteins (Binding Protein)IBA 01/2023 - 08/2010
5	Anti-Bacterial Agents (Antibiotics)IBA 12/2022 - 09/2003
5	Polysaccharides (Glycans)IBA 01/2022 - 05/2009
4	AntibodiesIBA 01/2020 - 05/2009
3	Capsules (Microcapsules)IBA 05/2024 - 01/2014
3	lufotrelvirIBA 08/2023 - 02/2021
3	Complement Factor H (Factor H)IBA 01/2017 - 08/2010
3	factor AIBA 03/2016 - 05/2009
3	Proteins (Proteins, Gene)FDA Link 03/2016 - 05/2009
2	O Antigens (O Antigen)IBA 05/2024 - 01/2022
2	BNT162 VaccineIBA 03/2024 - 09/2023
2	Immunoglobulin G (IgG)IBA 09/2023 - 05/2009
2	nirmatrelvir and ritonavir drug combinationIBA 01/2022 - 01/2022
2	nirmatrelvirIBA 01/2022 - 01/2022
2	Peptide Hydrolases (Proteases)FDA Link 01/2022 - 02/2021
2	remdesivirIBA 10/2021 - 02/2021
2	Complement System Proteins (Complement)IBA 01/2020 - 01/2017
2	Conjugate VaccinesIBA 01/2019 - 10/2018
2	Virulence Factors (Pathogenicity Factors)IBA 01/2014 - 10/2012
1	mRNA VaccinesIBA 03/2024
1	Messenger RNA (mRNA)IBA 03/2024
1	baricitinibIBA 01/2023
1	3'-(1-butylphosphoryl)adenosineIBA 01/2023
1	tocilizumab (atlizumab)FDA Link 01/2023
1	Immunomodulating AgentsIBA 01/2023
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2023
1	Monoclonal AntibodiesIBA 01/2023
1	GlycoconjugatesIBA 01/2022
1	Protease Inhibitors (Protease Inhibitor)IBA 10/2021
1	AntipyreticsIBA 01/2021
1	SolutionsIBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 01/2017
1	LipidsIBA 11/2016
1	Lipoproteins (Lipoprotein)IBA 11/2016
1	ElementsIBA 09/2016
1	Immune Sera (Antisera)IBA 08/2015
1	Formaldehyde (Formol)FDA Link 07/2013
1	CoagulaseIBA 10/2012
1	Fibrinogen (Factor I)FDA Link 10/2012
1	Neisseria meningitidis factor H-binding proteinIBA 11/2010
1	IronIBA 05/2009
1	aluminum hydroxyphosphate sulfateIBA 04/2006
1	Methicillin (Metin)FDA Link 04/2006
1	Linezolid (Zyvox)FDA Link 09/2003

Therapy/Procedure

6	Therapeutics 08/2023 - 09/2003
2	Prostheses and Implants (Prosthesis) 06/2013 - 09/2003
1	Intravenous Infusions 08/2023
1	Intramuscular Injections 01/2021
1	Spinal Fusion (Spondylosyndesis) 01/2017
1	Renal Dialysis (Hemodialysis) 06/2013
1	Catheters 09/2003